Cargando…

DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity

Diacylglycerol kinases (DGKs) attenuate diacylglycerol (DAG) signaling by converting DAG to phosphatidic acid, thereby suppressing pathways downstream of T cell receptor signaling. Using a dual DGKα/ζ inhibitor (DGKi), tumor-specific CD8 T cells with different affinities (TRP1(high) and TRP1(low)),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kureshi, Rakeeb, Bello, Elisa, Kureshi, Courtney T.S., Walsh, Michael J., Lippert, Victoria, Hoffman, Megan T., Dougan, Michael, Longmire, Tyler, Wichroski, Michael, Dougan, Stephanie K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2023
Materias:	Biomedicine and Life Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672170/ https://www.ncbi.nlm.nih.gov/pubmed/38000024 http://dx.doi.org/10.1126/sciadv.adk1853

Ejemplares similares

Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
por: Walsh, Michael J, et al.
Publicado: (2023)

DGKζ exerts greater control than DGKα over CD8(+) T cell activity and tumor inhibition
por: Gu, Junchen, et al.
Publicado: (2021)

IFNγ is a central node of cancer immune equilibrium
por: Walsh, Michael J., et al.
Publicado: (2023)

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023)

DGKζ Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma
por: Gu, Xuefeng, et al.
Publicado: (2019)

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
por: Manfredi, Francesco, et al.
Publicado: (2023)

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
por: Savage, Thomas M., et al.
Publicado: (2023)

The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation
por: Ma, Victor Pui-Yan, et al.
Publicado: (2022)

SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes
por: Tello-Lafoz, M., et al.
Publicado: (2017)

Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
por: Kim, Hyungsoo, et al.
Publicado: (2023)

SMAD4, activated by the TCR-triggered MEK/ERK signaling pathway, critically regulates CD8(+) T cell cytotoxic function
por: Liu, Xinwei, et al.
Publicado: (2022)

DGK α and ζ Activities Control T(H)1 and T(H)17 Cell Differentiation
por: Yang, Jialong, et al.
Publicado: (2020)

ERK3 and DGKζ interact to modulate cell motility in lung cancer cells
por: Myers, Amanda K., et al.
Publicado: (2023)

Microfluidic affinity selection of active SARS-CoV-2 virus particles
por: Gamage, Sachindra S. T., et al.
Publicado: (2022)

Native holdup (nHU) to measure binding affinities from cell extracts
por: Zambo, Boglarka, et al.
Publicado: (2022)

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes
por: Wang, Shuren, et al.
Publicado: (2022)

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation
por: Kissel, Theresa, et al.
Publicado: (2022)

TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity
por: Bi, Jiacheng, et al.
Publicado: (2021)

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
por: Ogunnaike, Edikan A., et al.
Publicado: (2021)

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
por: Piunti, Andrea, et al.
Publicado: (2022)

Sexually dimorphic activation of innate antitumor immunity prevents adrenocortical carcinoma development
por: Wilmouth, James J., et al.
Publicado: (2022)

TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
por: Sun, Rui, et al.
Publicado: (2023)

Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response
por: Chen, Siyu, et al.
Publicado: (2023)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses
por: Wu, Yaoying, et al.
Publicado: (2022)

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022)

Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells
por: Osterlund, Elizabeth J., et al.
Publicado: (2022)

Polysome propensity and tunable thresholds in coding sequence length enable differential mRNA stability
por: Rahaman, Sayanur, et al.
Publicado: (2023)

Directed assembly of genetically engineered eukaryotic cells into living functional materials via ultrahigh-affinity protein interactions
por: Yi, Qikun, et al.
Publicado: (2022)

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
por: Walle, Thomas, et al.
Publicado: (2022)

Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
por: Smith, Rasheid, et al.
Publicado: (2022)

Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models
por: Lin, Regina J., et al.
Publicado: (2023)

Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8(+) T cells
por: Das, Jugal Kishore, et al.
Publicado: (2022)

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies
por: Wang, Daniel, et al.
Publicado: (2023)

Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity
por: Sun, Runzi, et al.
Publicado: (2023)

ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation
por: Yang, Yuanqin, et al.
Publicado: (2021)

PTPN2 elicits cell autonomous and non–cell autonomous effects on antitumor immunity in triple-negative breast cancer
por: Goh, Pei Kee, et al.
Publicado: (2022)

Therapeutic KRAS(G12C) inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
por: Mugarza, Edurne, et al.
Publicado: (2022)

SMYD2 inhibition–mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity
por: Tang, Ming, et al.
Publicado: (2023)

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
por: Kamerkar, Sushrut, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95sf4o6770jcifd4cq1257vu2b